SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-006561
Filing Date
2020-11-16
Accepted
2020-11-16 09:00:44
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 578270
2 CERTIFICATION ipix_ex311.htm EX-31.1 9775
3 CERTIFICATION ipix_ex321.htm EX-32.1 3863
  Complete submission text file 0001477932-20-006561.txt   3834226

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ipix-20200930.xml EX-101.INS 583172
5 XBRL TAXONOMY EXTENSION SCHEMA ipix-20200930.xsd EX-101.SCH 68461
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20200930_lab.xml EX-101.LAB 331325
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20200930_cal.xml EX-101.CAL 46257
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20200930_pre.xml EX-101.PRE 319011
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20200930_def.xml EX-101.DEF 235690
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 201313957
SIC: 2834 Pharmaceutical Preparations